Pioglitazone Oral Tablets manufacturers & suppliers

Pioglitazone Oral Tablets

Form: Oral Tablets

Strength: 15 mg, 30 mg, 45 mg

Reference Brands: Actos (USA, EU), Glustin (EU)

Category: Diabetes

Pioglitazone tablets are FDA-approved in the USA and authorized by the EMA in the EU for the treatment of type 2 diabetes mellitus, either as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas. Marketed under brands such as Actos, Glustin, and their generics, pioglitazone is classified as a thiazolidinedione. It improves glycemic control by enhancing insulin sensitivity in muscle and adipose tissues. Regulatory agencies emphasize cardiovascular risk evaluation and monitor for adverse effects like weight gain and edema. Pharmatradz.com offers regulatory-compliant sourcing and B2B access to pioglitazone from audited manufacturers globally.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Premixed Insulins (70/30, 50/50) Injectable

Strength: U-100

Form: Vials, pens

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

View Details
Insulin Lispro (Humalog) Injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)

View Details
Insulin Aspart (Novolog) Injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Novolog, Fiasp(US &EU)

View Details
Insulin Glargine (Lantus) Injectable

Strength: U-100, U-300

Form: Vials/pens

Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.